| Advancement in leishmaniasis diagnosis and therapeutics: An update D Kumari, S Perveen, R Sharma, K Singh European Journal of Pharmacology 910, 174436, 2021 | 49 | 2021 |
| Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance S Perveen, D Kumari, K Singh, R Sharma European Journal of Medicinal Chemistry 229, 114066, 2022 | 35 | 2022 |
| Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets D Kumari, S Mahajan, P Kour, K Singh Life sciences 306, 120829, 2022 | 15 | 2022 |
| Exploring the paradox of defense between host and Leishmania parasite D Kumari, K Singh International immunopharmacology 102, 108400, 2022 | 13 | 2022 |
| Design, synthesis, and biological evaluation of 3, 3′-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity P Kour, P Saha, S Bhattacharya, D Kumari, A Debnath, A Roy, ... RSC Medicinal Chemistry 14 (10), 2100-2114, 2023 | 4 | 2023 |
| Safety of Nanoparticles: Emphasis on Antimicrobial Properties K Singh, S Ahlawat, D Kumari, U Matlani, Meenakshi, T Kaur, A Rao Biomedical Applications and Toxicity of Nanomaterials, 425-458, 2023 | 2 | 2023 |
| Design, synthesis, and biological evaluation of eugenol-isoxazoline hybrid derivatives as potential anti-leishmanial agents D Rani, D Kumari, A Bhushan, V Jamwal, BA Lone, G Lakhanpal, ... Journal of Molecular Structure 1308, 138105, 2024 | 1 | 2024 |
| Amphotericin B loaded nanoemulsion: Optimization, characterization and in-vitro activity against L. donovani promastigotes VM Prajapat, M Aalhate, A Sriram, S Mahajan, I Maji, U Gupta, D Kumari, ... Parasitology International 100, 102848, 2024 | 1 | 2024 |
| Anhydroparthenin as a dual-target inhibitor against Sterol C-24 methyltransferase and Sterol 14-α demethylase of Leishmania donovani: A comprehensive in vitro and in silico study D Kumari, P Kour, CP Singh, R Choudhary, SM Ali, S Bhayye, ... International Journal of Biological Macromolecules 269, 132034, 2024 | | 2024 |
| A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy N Sakander, A Ahmed, M Bhardwaj, D Kumari, U Nandi, D Mukherjee Bioorganic Chemistry, 107379, 2024 | | 2024 |
Kuljit SinghScientist@CSIR-IIIM, JAMMU在 iiim.res.in 的电子邮件经过验证
